Evidence map›Paper›PMID 37255709›Full record

ArticleFrontiers in cardiovascular medicine2023

Ultra-high field cardiac MRI in large animals and humans for translational cardiovascular research.

Laura M Schreiber, David Lohr, Steffen Baltes, Ulrich Vogel, Ibrahim A Elabyad, Maya Bille, Theresa Reiter, Aleksander Kosmala, Tobias Gassenmaier, Maria R Stefanescu and 13 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. 7TMagnetic resonance in medicine · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 2 institutions in 1 country.

Laura M SchreiberDepartment of Cardiovascular Imaging and Chair of Molecular and Cellular Imaging, Comprehensive Heart Failure Center Wuerzburg (CHFC), University Hospital Wuerzburg, Wuerzburg, Germany.
David LohrDepartment of Cardiovascular Imaging and Chair of Molecular and Cellular Imaging, Comprehensive Heart Failure Center Wuerzburg (CHFC), University Hospital Wuerzburg, Wuerzburg, Germany.
Steffen BaltesDepartment of Cardiovascular Imaging and Chair of Molecular and Cellular Imaging, Comprehensive Heart Failure Center Wuerzburg (CHFC), University Hospital Wuerzburg, Wuerzburg, Germany.
Ulrich VogelInstitute for Hygiene and Microbiology, University of Wuerzburg, Wuerzburg, Germany.
Ibrahim A ElabyadDepartment of Cardiovascular Imaging and Chair of Molecular and Cellular Imaging, Comprehensive Heart Failure Center Wuerzburg (CHFC), University Hospital Wuerzburg, Wuerzburg, Germany.
Maya BilleDepartment of Cardiovascular Imaging and Chair of Molecular and Cellular Imaging, Comprehensive Heart Failure Center Wuerzburg (CHFC), University Hospital Wuerzburg, Wuerzburg, Germany.
Theresa ReiterDepartment of Cardiovascular Imaging and Chair of Molecular and Cellular Imaging, Comprehensive Heart Failure Center Wuerzburg (CHFC), University Hospital Wuerzburg, Wuerzburg, Germany.
Aleksander KosmalaDepartment of Cardiovascular Imaging and Chair of Molecular and Cellular Imaging, Comprehensive Heart Failure Center Wuerzburg (CHFC), University Hospital Wuerzburg, Wuerzburg, Germany.
Tobias GassenmaierDepartment of Cardiovascular Imaging and Chair of Molecular and Cellular Imaging, Comprehensive Heart Failure Center Wuerzburg (CHFC), University Hospital Wuerzburg, Wuerzburg, Germany.
Maria R StefanescuDepartment of Cardiovascular Imaging and Chair of Molecular and Cellular Imaging, Comprehensive Heart Failure Center Wuerzburg (CHFC), University Hospital Wuerzburg, Wuerzburg, Germany.
Alena KollmannDepartment of Cardiovascular Imaging and Chair of Molecular and Cellular Imaging, Comprehensive Heart Failure Center Wuerzburg (CHFC), University Hospital Wuerzburg, Wuerzburg, Germany.
Julia AuresDepartment of Cardiovascular Imaging and Chair of Molecular and Cellular Imaging, Comprehensive Heart Failure Center Wuerzburg (CHFC), University Hospital Wuerzburg, Wuerzburg, Germany.
Florian SchnitterDepartment of Internal Medicine I/Cardiology, University Hospital Wuerzburg, Wuerzburg, Germany.
Mihaela PaliDepartment of Cardiovascular Imaging and Chair of Molecular and Cellular Imaging, Comprehensive Heart Failure Center Wuerzburg (CHFC), University Hospital Wuerzburg, Wuerzburg, Germany.
Yuichiro UedaInstitute of Anatomy and Cell Biology, Julius-Maximilians-University, Wuerzburg, Germany.
Tatiana WilliamsDepartment of Cardiovascular Genetics, Comprehensive Heart Failure Center Wuerzburg, University Hospital Wuerzburg, Wuerzburg, Germany.
Martin ChristaDepartment of Internal Medicine I/Cardiology, University Hospital Wuerzburg, Wuerzburg, Germany.
Ulrich HofmannDepartment of Internal Medicine I/Cardiology, University Hospital Wuerzburg, Wuerzburg, Germany.
Wolfgang BauerDepartment of Internal Medicine I/Cardiology, University Hospital Wuerzburg, Wuerzburg, Germany.
Brenda GerullDepartment of Internal Medicine I/Cardiology, University Hospital Wuerzburg, Wuerzburg, Germany.
Alma ZerneckeInstitute of Experimental Biomedicine, University Hospital Wuerzburg, Wuerzburg, Germany.
Süleyman ErgünInstitute of Anatomy and Cell Biology, Julius-Maximilians-University, Wuerzburg, Germany.
Maxim TerekhovDepartment of Cardiovascular Imaging and Chair of Molecular and Cellular Imaging, Comprehensive Heart Failure Center Wuerzburg (CHFC), University Hospital Wuerzburg, Wuerzburg, Germany.
Universitätsklinikum Würzburg · DEUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A key step in translational cardiovascular research is the use of large animal models to better understand normal and abnormal physiology, to test drugs or interventions, or to perform studies which would be considered unethical in human subjects. Ultrahigh field magnetic resonance imaging (UHF-MRI) at 7 T field strength is becoming increasingly available for imaging of the heart and, when compared to clinically established field strengths, promises better image quality and image information content, more precise functional analysis, potentially new image contrasts, and as all

Indexed as

cardiovascular MRIheartlarge animal modelsorganoidpigresearch infrastructuretranslational researchultrahigh-field MRI

Identifiers

PMID37255709
PMCPMC10225557
OpenAlexW4376615336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.